Valuation: DexCom, Inc.

Market Cap 32.95B 28.63B 26.73B 24.54B 46.28B 3,140B 47.08B 315B 123B 1,566B 124B 121B 5,165B P/E 2026 *
35.2x
P/E 2027 * 29.7x
Enterprise Value 32.33B 28.1B 26.23B 24.08B 45.41B 3,081B 46.2B 309B 121B 1,537B 121B 119B 5,068B EV / Sales 2026 *
6.18x
EV / Sales 2027 * 5.49x
Free-Float
92.53%
Yield 2026 *
-
Yield 2027 * -
1 day+4.63%
1 week+19.00%
Current month+4.63%
1 month+22.54%
3 months+42.31%
6 months+21.89%
Current year+31.55%
1 week 73.24
Extreme 73.24
87.63
1 month 69.74
Extreme 69.74
87.63
Current year 56.72
Extreme 56.72
87.63
1 year 54.11
Extreme 54.11
87.63
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Date Insider Type Main position Quantity % Market Cap.
7/20/26 Sell

Chairman

-26,756 0.0069%
7/15/26 Sell

General Counsel

-1,700 0.0004%
7/6/26 Sell

Chairman

-26,756 0.0069%
Change 5-day change 1-year change 3-year change Capi.($)
+4.63%+19.00%+10.13%-28.48% 32.95B
+1.34%+2.52%-15.85%-0.39% 185B
+1.51%+2.92%-2.98%+2.59% 111B
-0.95%-0.89%+6.94%+61.15% 60B
+1.98%+8.72%+42.54%+58.27% 53.9B
+2.77%+7.10%-3.49%-36.65% 46.9B
+3.03%+1.94% - - 34.22B
+2.05%+5.04%+45.42%-5.89% 24.49B
+1.86%+6.52%+2.54%+3.17% 22.67B
+0.39%+1.31%-8.86%+5.63% 21.75B
Average +1.85%+4.93%+8.49%+6.60% 59.32B
Weighted average by Cap. +1.60%+3.73%+1.05%+7.90%

Financials

2026 *2027 *
Net sales 5.23B 4.55B 4.24B 3.9B 7.35B 499B 7.47B 50.04B 19.6B 249B 19.65B 19.21B 820B 5.8B 5.04B 4.71B 4.32B 8.15B 553B 8.29B 55.5B 21.74B 276B 21.79B 21.31B 909B
Net income 971M 844M 788M 723M 1.36B 92.55B 1.39B 9.29B 3.64B 46.15B 3.65B 3.57B 152B 1.14B 993M 927M 851M 1.6B 109B 1.63B 10.93B 4.28B 54.28B 4.29B 4.19B 179B
Net Debt -619M -538M -502M -461M -869M -58.99B -884M -5.92B -2.32B -29.42B -2.32B -2.27B -97.02B -1.11B -962M -898M -825M -1.55B -106B -1.58B -10.59B -4.15B -52.62B -4.16B -4.07B -174B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-08-03 $87.31 +4.63% 9,191,480
26-07-31 $83.45 +11.95% 11,982,034
26-07-30 $74.54 -0.80% 5,653,473
26-07-29 $75.14 +0.39% 6,270,154
26-07-28 $74.85 +2.02% 4,120,276
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
87.31USD
Average target price
93.44USD
Spread / Average Target
+7.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock